West Pharmaceutical Services, Inc. will present at multiple investor conferences in September, including the Wells Fargo 2025 Healthcare Conference, Deutsche Bank 2025 Healthcare Summit, and Bank of America Global Healthcare Conference. The company's presentations will feature a fireside chat at the Wells Fargo conference and Bank of America conference, and investor meetings at the Deutsche Bank summit. The live webcasts of the events will be available on the company's website.
Title: West Pharmaceutical Services, Inc. to Present at Key Investor Conferences in September 2025
West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, has announced its participation in several prominent investor conferences in September 2025. The company will present at the Wells Fargo 2025 Healthcare Conference, the Deutsche Bank 2025 Healthcare Summit, and the Bank of America Global Healthcare Conference. These presentations aim to provide investors with insights into West's strategic initiatives and financial performance.
The Wells Fargo 2025 Healthcare Conference will feature a fireside chat at 3:00 PM ET on Wednesday, September 3, 2025, in Boston, MA. The live webcast of this event will be available on the Investor Webpage and a replay will be accessible on the company's website for approximately 90 days after the event [1].
At the Deutsche Bank 2025 Healthcare Summit, scheduled for Wednesday, September 10, 2025, in New York City, NY, West Pharmaceutical will hold investor meetings [1].
The Bank of America Global Healthcare Conference will also feature a fireside chat at 3:05 PM GMT on Wednesday, September 24, 2025, in London, UK. Similar to the other events, the live webcast of this conference will be available on the Investor Webpage and a replay will be available on the company's website for approximately 90 days after the event [1].
West Pharmaceutical Services, Inc. is a trusted partner to both established and emerging drug developers, ensuring the safe and effective containment and delivery of life-saving and life-enhancing medicines. With over 10,000 team members across 50 sites and 25 manufacturing facilities worldwide, the company delivered over 41 billion components and devices in 2024. Headquartered in Exton, Pennsylvania, West generated $2.89 billion in net sales for its fiscal year 2024. The company is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index [1].
These investor conferences provide an opportunity for West Pharmaceutical to engage with investors and stakeholders, offering a platform to discuss the company's strategic vision and financial performance. The live webcasts will allow investors who cannot attend the events in person to participate virtually.
References
[1] https://www.marketscreener.com/news/west-to-participate-in-upcoming-investor-conferences-in-september-2025-ce7c51d3dc8afe25
[2] https://finance.yahoo.com/news/west-participate-upcoming-investor-conferences-100000502.html
Comments
No comments yet